Edwards Lifesciences Corporation (EW)

About Edwards Lifesciences Corporation (EW)

Edwards Lifesciences Corp. engages in patient-focused medical innovations for heart disease and critical care monitoring. Its products are categorized into four main areas: Transcatheter Aortic Valve Replacement, Transcatheter Mitral and Tricuspid Therapies, Surgical Structural Heart, and Critical Care. It operates through the following geographical segments: United States, Europe, Japan, and Rest of World. The company was founded by Miles Lowell Edwards in 1958 and is headquartered in Irvine, CA.

Details

Daily high

$71.56

Daily low

$70.32

Price at open

$70.87

52 Week High

$96.12

52 Week Low

$58.93

Market cap

41.8B

Dividend yield

0.00%

Volume

3.0M

Avg. volume

4.8M

P/E ratio

29.02

Edwards Lifesciences Corporation News